Roundtable on Black in cancer research and oncology - presented by Dr. Brandon Blue MD and Dr. Kilan Ashad-Bishop and Drs. Onyinye and Folu Balogun and Runcie C.W. Chidebe Dip., BSc., MSc., and Kathryn Mcginnis and Dr Paraskevi Mallini and Dr. Lisa Hoffmann-Haas

Roundtable on Black in cancer research and oncology

Brandon Blue, Kilan Ashad-Bishop, Onyinye and Folu Balogun and Runcie C.W. Chidebe

Dr. Brandon Blue MDDr. Kilan Ashad-BishopDrs. Onyinye and Folu BalogunRuncie C.W. Chidebe Dip., BSc., MSc.,
Slide at 32:04
SHOW TASKBAR DISPLAY SETTINGS Y END SLIDE SHOW 0:00:30 II 9:34 AM Next slide The State of Cano www.projectpinkblue.org Our Stories: Our Examples Runcie Chidebe @projectpinkblue Age-standardized (World) incidence rates per sex Other cancers 49 142.7% Example 1: Where to go for Cancer Care? Non Hodgkin $ 363 (4.6%) Total 954 ONigeria is country in West Africa 0Less than 80 Oncologists for 206million people 0A population of over 206million people 0115,950 new cases of cancer annually Cancer is a critical public health problem in 070,327 cancer deaths annually Nigeria Over 70% of cancer are late/advanced stages 0Poor treatment outcome compared with Only 9 Radiotherapy machines other parts of the world ©Nigeria require $308million for Cancer Control 20 Example 2: Men are not interested in Cancer! www.projectpinkblue.org @projectpinkblu No Notes. Example 3: Can I get optimum Treatment? Example 4: Patients' Voices: The Missing Link www.projectpinkblue.org @projectpinkblue@runciecwo Slide 3 of 26
1
2
References
  • 1.
    https://twitter.com/runciecwc
  • 2.
    https://twitter.com/projectpinkblue
Share slide
Summary (AI generated)

We often hear the argument that there is a lack of data and infrastructure to generate this data. However, I have a different perspective - if there is a dearth of data, we should strive to create it. Allow me to provide a few examples of the initiatives we have undertaken and are currently undertaking in Nigeria. These examples serve to demonstrate what is possible and to highlight the potential for Nigeria, Africa, and numerous other low and middle-income countries to spearhead advancements in cancer control. This includes addressing the incidence and mortality rates, conducting clinical research, and various other aspects related to cancer control.